Bifidobacterium breve 30 capsules (3 billion CFU/capsule)


The use of Bifidobacterium breve probiotics has shown an anti-inflammatory effect, positive results in adjusting the microbial composition1 in patients with Celiac disease, resulting in decreased constipation-related symptoms2. B. breve is also used as a prevention for gastrointestinal symptom3 and rebalance the intestinal microbiota in infants and children4.


Dosage: 3 billion CFU per capsule

Capsules per order: 30 capsules

Instructions: 1 capsule daily (morning)


  1. Quagliariello A. et al. Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study. Nutrients. 2016 Oct 22;8(10). pii:E660.
  2. Primec M. et al. Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-a and short-chain fatty acids. Clinical Nutrition 2018, 1-9.
  3. Aloisio I. et al. Three-Month Feeding Integration with Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns. Frontiers in Nutrition, May 2018, art. 39.
  4. Mogna L. et al. Capability of the Two Microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to Colonize the Intestinal Microbiota of Children J Clin Gastroenterol, 2014. Suppl. 1, November/December, Vol. 48.